Tenax Therapeutics, Inc. · NASDAQ:TENX
Stonepine Capital Management, LLC's stake in Tenax Therapeutics, Inc. fell to 3.70% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Stonepine Capital Management, LLC's stake in Tenax Therapeutics, Inc. fell to 3.70%, 975,200 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.70%
- Shares
- 975,200
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Stonepine Capital Management, LLC | 3.70% | 975,200 |
| Stonepine Capital, L.P. | 3.70% | 975,200 |
| Stonepine GP, LLC | 3.70% | 975,200 |
| Jon M. Plexico | 3.70% | 975,200 |
Source
Related
- Tenax Therapeutics, Inc.
- Stonepine Capital Management, LLC
- Tenax Therapeutics, Inc. shareholders
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026